Urinary Incontinence in Traditional Iranian Medicine
Tārīkh-i pizishkī i.e., Medical History,
Vol. 7 No. 23 (1394),
17 December 2015
,
Page 99-126
https://doi.org/10.22037/mhj.v7i23.10807
Abstract
ICS (International continence society) has explained urinary incontinence as any loss of urine involuntarily. UI (urinary incontinence) is not a mortal condition but has many adverse effects on patients’ quality of life. Studies have shown a high prevalence of UI among women, especially in older ages and higher body mass index.
Due to intervention of UI with religious activities, demand for treatment of UI is more serious in our country. It is believed that all the kinds of drug therapy and surgeries have many side side effects especially in old patients. On the other hand it seems that Iranian Traditional Medicine can manage this disease as a hypothesis. So a plan was programmed as a first step to review philosopher’s approach to diseases specially UI.
Terms "salasolbol" and "bolfelferash" which mean loss of urine involuntarily and enuresis respectively, were considered equivalent for UI. Causes and treatments of these conditions were excluded and written in this review article. Based on ancient’s opinion, the most causes of UI is "cold" and "wet" of bladder and "esterkha" of external sphincter which make them be weak and lost their internal natural powers specially "maseke" which is bladder’s power for holding urine.
Signs and symptoms of patients who suffer from UI, even their laboratories studies on the basis of traditional medicine, confirm this idea. It seems new view from an old but original frame of traditional medicine to UI can introduce effective way for treating urinary incontinence.
- Urinary Incontinence, Iranian Traditional Medicine, Salasolbol, Bolfelferash, Estrkha
How to Cite
References
Legendre G, Ringa V, Fauconnier A, Fritel X. Menopause, hormone treatment and urinary incontinence at midlife. Maturitas. 2013; 74 (1): 26-30.
Yip SK, Cardozo L. Psychological morbidity and female urinary incontinence. Best Practice and Research Clinical Obstetrics and Gynecology. 2007; 21 (2): 321-9.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Kerrebroeck PV, Victor A, Wein A. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21 (2): 167-78.
Herzog AR, Diokno AC, Brown MB, Fultz NH, Goldstein NE. Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc. 1994; 42 (3): 264-8.
Minassian VA, Drutz HP, Al-Badr A .Urinary incontinence as a worldwide problem. Int J Gynaecol Obstet. 2003; 82: 327-38.
Tennstedt SL, Chiu GR, Link CL, Litman HJ, Kusek J, McKinlay JB. The effects of severity of urine leakage on quality of life in Hispanic, white and black men and women: The Boston Area Community Health Survey. Urology. 2009; 75: 27-33.
Minassian VA, Devore E, Hagan K, Grodstein F. Severity of urinary incontinence and effect on quality of life in women by incontinence type. Obstet Gynecol. 2013; 121: 1083-90.
Hajebrahimi S, Madaen SK. Prevalence of urinary incontinence in Tabrizian women. Iranian J Urol. 2001; 61-4.
Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300 (11): 1311-6.
Yip SK, Cardozo L. Psychological morbidity and female urinary incontinence. Best Practice and Research Clinical Obstetrics and Gynecology. 2007; 21 (2): 321-9.
Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008; 101 (11): 1388-95.
Capasso R, Borrelli F, Capasso F, Mascolo N, Izzo AA. Inhibitory effect of the antidepressant St. John’s wort (hypericum perforatum) on rat bladder contractility in vitro. Urology. 2004; 64: 168-72.
Brown JS, Vittinghoff E, Wyman JF, Stone KL, Nevitt MC, Ensrud KE, Grady D. Urinary incontinence: does it increased risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000; 48 (7): 721-5.
Andersson KE. The pharmacological treatment of urinary incontinence. BJU International. 1999; 84: 923-47.
Bloom DA, McGuire EJ, Lapides J. A brief history of urethral catheterization. J Urol. 1994; 151 (2): 317-25.
Schultheiss D. A Brief History of Urinary Incontinence and its Treatment. Incontinence. 2009; 19-34.
Aghili Khorasani SMH. Kholase al Hekma. Correction by professor Nazim. 1385; 1: 366-7.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 411.
Aghili Khorasani SMH. Kholase al Hekma. Correction by professor Nazim. 1385; 1: 336.
Ebne Nafis. Sharhr Tashrihe ghanon, Online PDF file, 245.
Chaghminy M. Ghanunche dar teb. Correction by professor Nazim. 1390; 49.
Arzani Hakim MA. Mofarraholgholub, Sharhe ghanunche dar teb. 41.
Ibn Sina. Ghanon fi Alteb. 2009; 1: 46.
Ibn Sina. Ghanon fi Alteb. 2009; 1: 81.
Ibn Sina. Ghanon fi Alteb. 2009; 1: 92.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 435.
Heravi M. Bahroljavaher. 1387; 215.
Heravi M. Bahroljavaher. 1387; 87.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 437.
Kirmani N. Sharh al asbab va al alamat. 1387; 2: 172.
Ahvazi A. Kamel Alsanaa Altabyh. 1387; 2: 38.
Jarjani SE. Zakhireye Kharazmshahy. 1380; 1: 150.
Chaghminy M. Ghanunche dar teb. Correction by professor Nazim. 1390; 89.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 412.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 423.
Jarjani SE. Zakhireye Kharazmshahy. 1380; 1: 15.
Kirmani N. Sharh al asbab va al alamat. 1387; 2: 126.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 435-6.
Choshty, MAK. Exir e Azam. 3: 516.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 422.
Arzani Hakim MA. Teb e Akbari. 1387; 1: 114.
Heravi M. Bahroljavaher. 1387; 31.
Arzani Hakim MA. Teb e Akbari. 1387; 2: 111.
Ibn Sina. Ghanon fi Alteb. 2009; 3: 437.
Arzani Hakim MA. Teb e Akbari. 1387; 1: 112.
Ebne Fakhreddine Shirazi MF. Kolliate Ghanone Ibn Sina. Persian transalation. 1386; 83-4.
Kirmani N. Sharh al asbab va al alamat. 1387; 1: 174.
Ibn Sina. Ghanon fi Alteb. 2009; 1: 272.
Choshty, MAK. Exir e Azam. 3: 516-21.
Hansen RB, Biering Sorensen F, Kvist Kristensen J. Urinary incontinence in spinal cord injured individuals 10-45 years after injury. Spinal Cord. 2010; 48: 27-33.
Lukacz ES, Sampselle C, Gray M, MacDiarmid S, Rosenberg M, Ellsworth P, Palmer MH. A healthy bladder: a consensus statement. Int J Clin Pract. 2011; 65 (10): 1026-36.
Gungor I, Kizilkaya BN. Lifestyle changes for the prevention and management of lower urinary tract symptoms in women. International Journal of Urological Nursing. 2011; 5 (1): 3-13.
Hunskaar S. Epidemiology of Urinary (UI) and Faecal (FI) Incontinence and Pelvic Organ Prolapse (POP). 2009; 274.
Moller LA, Lose G, Jorgenson T. Risk factors for lower urinary tract symptoms in women 40-60 years of age. Obstet Gynecol. 2000; 96: 446-51.
Rortveit G, Hannestad YS, Daltveit AK, Hunskaar S. Age and type dependent effects of parity on urinary incontinence: the Norwegian Epincont study. Obstet Gynecol. 2001; 98: 1004-10.
Khullar V, Sexton CC, Thompson CL, Milsom I, Bitoun CE, Coyne KS. The relationship between BMI and urinary incontinence subgroups: Results from EpiLUTS. Neurourology and Urodynamics. 2014; 33 (4): 392-9.
Ibn Sina. Ghanon fi Alteb. 2009; 1: 30-3.
Michel MC, Barendrecht MM. Physiological and pathological regulation of the autonomic control of urinary bladder contractility. Pharmacology and Therapeutics. 2008; 117 (3): 297-312.
- Abstract Viewed: 5603 times
- PDF (فارسی) Downloaded: 3830 times